[Federal Register Volume 76, Number 186 (Monday, September 26, 2011)]
[Notices]
[Page 59414]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-24660]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
USC, as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, I/START Review Committee.
    Date: October 14, 2011.
    Time: 8 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Virtual Meeting).
    Contact Person: Mark Swieter, PhD, Chief, Extramural Activities 
Branch, Office of Extramural Affairs, National Institute on Drug 
Abuse, NIH, DHHS, Room 4235, MSC 9550, 6001 Executive Blvd., 
Bethesda, MD 20892-9550, 301-435-1389, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, B/START Review Committee.
    Date: October 14, 2011.
    Time: 8 a.m. to 8 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Virtual Meeting).
    Contact Person: Mark Swieter, PhD, Chief, Extramural Activities 
Branch, Office of Extramural Affairs, National Institute on Drug 
Abuse, NIH, DHHS, Room 4235, MSC 9550, 6001 Executive Blvd., 
Bethesda, MD 20892-9550, 301-435-1389, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Institutional Research Training Grants (T32).
    Date: November 3, 2011.
    Time: 10 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes 
Street, Arlington, VA 22202.
    Contact Person: Eliane Lazar-Wesley, PhD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 4245, MSC 9550, 6001 Executive Blvd., 
Bethesda, MD 20892-9550, 301-451-4530, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, NIDA-K Conflict.
    Date: November 3, 2011.
    Time: 5 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes 
Street, Arlington, VA 22202.
    Contact Person: Gerald L. McLaughlin, PhD, Chief, Grants Review 
Branch and Contracts Review Branch, Office of Extramural Affairs, 
National Institute on Drug Abuse, NIH, DHHS, Room 4238, MSC 9550, 
6001 Executive Blvd., Bethesda, MD 20892-9550, 301-402-6626, 
[email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Exploring Drugs of Abuse and Transgenerational 
Phenotypes (R01).
    Date: November 17, 2011.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Westin Washington, DC City Center, 1400 M Street, 
NW., Washington, DC 20005.
    Contact Person: Minna Liang, PhD, Scientific Review Officer, 
Grants Review Branch, Office of Extramural Affairs, National 
Institute on Drug Abuse, NIH, Room 4226, MSC 9550, 6001 Executive 
Blvd., Bethesda, MD 20892-9550, 301-435-1432, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, NIDA Cutting-Edge Basic Research Awards (CEBRA) 
(R21).
    Date: December 2, 2011.
    Time: 9 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Virtual Meeting).
    Contact Person: Scott A. Chen, PhD, Scientific Review 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, NIH, DHHS, Room 4234, MSC 9550, 6001 Executive Blvd., 
Bethesda, MD 20892-9550, 301-443-9511, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: September 20, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-24660 Filed 9-23-11; 8:45 am]
BILLING CODE 4140-01-P